BLOG > News & Events > Webinar: mRNA platform - Explocap™, a new cap analog to extend synthesis capabilities

Last week, we hosted our webinar on mRNA platform: Explocap™, a new cap analog to extend synthesis capabilities, presented in collaboration with ExploRNA Therapeutics.
First of all, we'd like to thank everyone who joined us for this session!
During this session, we go over mRNA applications, share insights about our mRNA custom platform, and present an overview of our synthesis capabilities and available modifications. ExploRNA Therapeutics introduced ExploCap™ and other cap analogs, supported by concrete in vivo data.
ExploCap™ is a next-generation co-transcriptional capping reagent designed to generate high-quality capped RNA with excellent biological properties. Developed by ExploRNA Therapeutics, ExploCap™ has been designed to flexibly fit various in vitro transcription (IVT) workflows providing reliable high-quality outcomes, opens new possibilities for custom mRNA production.
Topics covered:
- mRNA applications & custom platform
- mRNA synthesis capabilities & available modifications
- New cap analog: ExploCap™
- ExploRNA capping technology
Webinar hosted by Cédric Sapet, Ph.D. and Sofia Muret, Scientific Sales Manager from OZ Biosciences, alongside Marcelina Bednarczyk, Ph.D. from ExploRNA Therapeutics.
For those who couldn’t attend, the replay is now available:
Watch the ReplaySee all our webinars




